TCRx_T / TCRx Therap, Zhejiang University - LARVOL DELTA

TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy (clinicaltrials.gov) - P1 | N=50 | Not yet recruiting | Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Trial completion date: Aug 2027 ➔ Mar 2028 | Initiation date: Aug 2022 ➔ Mar 2023 | Trial primary completion date: Aug 2025 ➔ Mar 2026

Metastases • Trial completion date • Trial initiation date • Trial primary completion date • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • Oncology • Solid Tumor

Exploratory Clinical Study of TCRx_T Cells in the Treatment of Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy (clinicaltrials.gov) - P1 | N=50 | Not yet recruiting | Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

New P1 trial • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • Oncology • Solid Tumor